The front page of AI-driven biology
Thursday, October 15, 2026Thu, Oct 15
Updated 5:32 PM PT
The Advanced Research Projects Agency for Health has funded three teams under its BioStabilization Systems program, committing up to $87 million over four years to eliminate cold-chain refrigeration for living cell products.
Researchers built Hyper Screening X, a generative flow network that bakes reaction rules directly into design algorithms to search an 11-trillion make-on-demand compound library while scoring only 10 million candidates.
Life sciences equipment giant Danaher plans to launch its first autonomous research lab run by AI by early 2027, according to Reuters reporting.
Researchers at Sungkyunkwan University are developing a hybrid digital twin that couples physical bioprocess equations with explainable machine learning to run bioreactors autonomously.
An automated research platform named iCloudBiofoundry links AI agents that plan scientific protocols from literature with robotic laboratory hardware that executes experiments autonomously.
Researchers built MOMbot, an automated hardware and software platform that delivers chemical, electrical, mechanical, and thermal cues to biological specimens while an active-learning algorithm decides the next test.
MicroClaw is an artificial intelligence assistant designed to plan and execute automated imaging experiments across multiple microscope platforms using natural language prompts.
GenomeFrontier Therapeutics will adapt the production of GF-CART01, an autologous virus-free CAR T-cell therapy, to run on Cellares' automated Cell Shuttle system.
Cell therapy bioprocessing specialist Ori Biotech has agreed to a $120 million contract to implement its automated production platform for an undisclosed commercial-stage cell therapy.